berberine has been researched along with calcitriol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dowaki, R; Kadota, S; Li, H; Miyahara, T; Namba, T; Nemoto, N; Seto, H; Suzuki, T; Tezuka, Y; Tonami, S; Watanabe, M | 1 |
Cha, BY; Hasegawa, S; Iwahashi, A; Jeon, WB; Lee, JW; Nagai, K; Woo, JT; Yonezawa, T | 1 |
Bohlen, K; Callahan, L; Davies, GE; Downey, T; Ehli, EA; Hansen, R; Hu, Y; Huizenga, P; Jahnke, M; Kittelsrud, J; Marshall, LL; Munger, K; Munson, V; Nelson, K; Ronan, PJ; Soundy, TJ | 1 |
1 trial(s) available for berberine and calcitriol
Article | Year |
---|---|
Lipid-lowering effect of berberine in human subjects and rats.
Topics: Adult; Animals; Berberine; Calcitriol; Cholesterol; Coptis; Drugs, Chinese Herbal; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Obesity; Phytotherapy; Rats, Sprague-Dawley; Triglycerides; Weight Loss | 2012 |
2 other study(ies) available for berberine and calcitriol
Article | Year |
---|---|
The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of berberine.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Berberine; Body Weight; Bone Density; Bone Resorption; Calcitonin; Calcitriol; Drugs, Chinese Herbal; Female; Interleukin-1; Macrolides; Male; Mice; Organ Size; Osteoclasts; Ovariectomy; Parathyroid Hormone; Rats; Rats, Wistar; Uterus | 1999 |
Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.
Topics: Animals; Berberine; Bone Density Conservation Agents; Bone Marrow Cells; Calcitriol; Cell Differentiation; Cell Survival; Cells, Cultured; Coculture Techniques; Dose-Response Relationship, Drug; Gene Expression Regulation; Male; Mice; NF-kappa B; NFATC Transcription Factors; Osteoblasts; Osteoclasts; Osteoprotegerin; Phosphorylation; RANK Ligand; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcription Factor RelA | 2012 |